Compliance with cGMP. CPL shall monitor and maintain reasonable records respecting its compliance with cGMP, including those referenced in the Quality Assurance Agreement, or as Helix may otherwise reasonably request from time to time. CPL further agrees to comply with any and all corrective actions mutually agreed to by the Parties pursuant to any audit performed pursuant to section 5.1.
Appears in 3 contracts
Sources: Topical Interferon Alpha 2b GMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement (Helix BioPharma Corp), GMP Process Development and Manufacturing Agreement (Helix BioPharma Corp), Topical Interferon Alpha 2b GMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement (Helix BioPharma Corp)